Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
BioDlink International (1875 HK)
Watchlist
74
Analysis
Health Care
•
China
Develops, manufactures and markets anti-tumor drugs
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
CK Hutchison
•
08 Feb 2026 06:15
Last Week In Event SPACE: CKH, Toyota Industries, Melco, Rio/Glencore, Guoco
It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...
David Blennerhassett
Follow
474 Views
Share
bullish
•
Hisamitsu Pharmaceutical Co
•
02 Feb 2026 06:30
Asia-Pac M&A, Jan 2026 Wrap: Hisamitsu Pharma, IJM Corp, Sankei Real Estate, BioDlink, Skyworth
For the month of Jan 2026, 6 new deals were discussed on Smartkarma with an overall deal size of ~US$8bn. The average premium for these new deals...
David Blennerhassett
Follow
338 Views
Share
bullish
•
Dongfeng Motor
•
02 Feb 2026 02:17
Merger Arb Mondays (02 Feb) - Dongfeng, ENN, Toyota Ind, Raksul, Sankei, Mandom, IJM, Webjet, Qube
I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
519 Views
Share
bullish
•
Hisamitsu Pharmaceutical Co
•
01 Feb 2026 06:15
Asia-Pac M&A Weekly Wrap: Bluescope Steel, Iress, Skyworth, Toyota Inds., Raksul, Sankei Real Estate
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
428 Views
Share
bullish
•
Toyota Industries
•
26 Jan 2026 02:20
Merger Arb Mondays (26 Jan) - Toyota Ind, Raksul, Mamezo, Skyworth, IJM, ENN, Australian Strategic
I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...
Arun George
Follow
681 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x